Skip to main content
Top
Published in: Diabetologia 8/2015

Open Access 01-08-2015 | Article

A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control

Authors: Noha A. Yousri, Dennis O. Mook-Kanamori, Mohammed M. El-Din Selim, Ahmed H. Takiddin, Hala Al-Homsi, Khoulood A. S. Al-Mahmoud, Edward D. Karoly, Jan Krumsiek, Kieu Thinh Do, Ulrich Neumaier, Marjonneke J. Mook-Kanamori, Jillian Rowe, Omar M. Chidiac, Cindy McKeon, Wadha A. Al Muftah, Sara Abdul Kader, Gabi Kastenmüller, Karsten Suhre

Published in: Diabetologia | Issue 8/2015

Login to get access

Abstract

Aims/hypothesis

Metabolomics has opened new avenues for studying metabolic alterations in type 2 diabetes. While many urine and blood metabolites have been associated individually with diabetes, a complete systems view analysis of metabolic dysregulations across multiple biofluids and over varying timescales of glycaemic control is still lacking.

Methods

Here we report a broad metabolomics study in a clinical setting, covering 2,178 metabolite measures in saliva, blood plasma and urine from 188 individuals with diabetes and 181 controls of Arab and Asian descent. Using multivariate linear regression we identified metabolites associated with diabetes and markers of acute, short-term and long-term glycaemic control.

Results

Ninety-four metabolite associations with diabetes were identified at a Bonferroni level of significance (p < 2.3 × 10−5), 16 of which have never been reported. Sixty-five of these diabetes-associated metabolites were associated with at least one marker of glycaemic control in the diabetes group. Using Gaussian graphical modelling, we constructed a metabolic network that links diabetes-associated metabolites from three biofluids across three different timescales of glycaemic control.

Conclusions/interpretation

Our study reveals a complex network of biochemical dysregulation involving metabolites from different pathways of diabetes pathology, and provides a reference framework for future diabetes studies with metabolic endpoints.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189PubMedCrossRef Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189PubMedCrossRef
2.
go back to reference Pauling L, Robinson AB, Teranishi R, Cary P (1971) Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 68:2374–2376PubMedCentralPubMedCrossRef Pauling L, Robinson AB, Teranishi R, Cary P (1971) Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 68:2374–2376PubMedCentralPubMedCrossRef
4.
go back to reference Menni C, Fauman E, Erte I et al (2013) Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62:4270–4276PubMedCentralPubMedCrossRef Menni C, Fauman E, Erte I et al (2013) Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62:4270–4276PubMedCentralPubMedCrossRef
5.
go back to reference Suhre K, Meisinger C, Doring A et al (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5, e13953PubMedCentralPubMedCrossRef Suhre K, Meisinger C, Doring A et al (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5, e13953PubMedCentralPubMedCrossRef
6.
go back to reference Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH (2010) Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 5, e15234PubMedCentralPubMedCrossRef Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH (2010) Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 5, e15234PubMedCentralPubMedCrossRef
7.
go back to reference Wang C, Kong H, Guan Y et al (2005) Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem 77:4108–4116PubMedCrossRef Wang C, Kong H, Guan Y et al (2005) Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem 77:4108–4116PubMedCrossRef
8.
go back to reference Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639–648PubMedCentralPubMedCrossRef Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639–648PubMedCentralPubMedCrossRef
9.
go back to reference Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311–326PubMedCentralPubMedCrossRef Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311–326PubMedCentralPubMedCrossRef
11.
go back to reference Gall WE, Beebe K, Lawton KA et al (2010) Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5:e10883PubMedCentralPubMedCrossRef Gall WE, Beebe K, Lawton KA et al (2010) Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5:e10883PubMedCentralPubMedCrossRef
13.
go back to reference Mook-Kanamori DO, El-Din Selim MM, Takiddin AH et al (2014) 1,5-Anhydroglucitol in saliva is a non-invasive marker of short-term glycemic control. J Clin Endocrinol Metab 99:E479–483 Mook-Kanamori DO, El-Din Selim MM, Takiddin AH et al (2014) 1,5-Anhydroglucitol in saliva is a non-invasive marker of short-term glycemic control. J Clin Endocrinol Metab 99:E479–483
14.
go back to reference McGill JB, Cole TG, Nowatzke W et al (2004) Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. Diabetes Care 27:1859–1865PubMedCrossRef McGill JB, Cole TG, Nowatzke W et al (2004) Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. Diabetes Care 27:1859–1865PubMedCrossRef
15.
go back to reference Krumsiek J, Suhre K, Illig T, Adamski J, Theis FJ (2011) Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Syst Biol 5:21PubMedCentralPubMedCrossRef Krumsiek J, Suhre K, Illig T, Adamski J, Theis FJ (2011) Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Syst Biol 5:21PubMedCentralPubMedCrossRef
16.
go back to reference Krumsiek J, Suhre K, Evans AM et al (2012) Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet 8, e1003005PubMedCentralPubMedCrossRef Krumsiek J, Suhre K, Evans AM et al (2012) Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet 8, e1003005PubMedCentralPubMedCrossRef
18.
go back to reference Altmaier E, Emeny RT, Krumsiek J et al (2013) Metabolomic profiles in individuals with negative affectivity and social inhibition: a population-based study of type D personality. Psychoneuroendocrinology 38:1299–1309PubMedCrossRef Altmaier E, Emeny RT, Krumsiek J et al (2013) Metabolomic profiles in individuals with negative affectivity and social inhibition: a population-based study of type D personality. Psychoneuroendocrinology 38:1299–1309PubMedCrossRef
19.
go back to reference Ried JS, Baurecht H, Stückler F et al (2013) Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. Allergy 68:629–636PubMedCrossRef Ried JS, Baurecht H, Stückler F et al (2013) Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. Allergy 68:629–636PubMedCrossRef
20.
go back to reference Do KT, Kastenmuller G, Mook-Kanamori DO et al (2014) Network-based approach for analyzing intra-and interfluid metabolite associations in human blood, urine, and saliva. J Proteome Res 14:1183–1194 Do KT, Kastenmuller G, Mook-Kanamori DO et al (2014) Network-based approach for analyzing intra-and interfluid metabolite associations in human blood, urine, and saliva. J Proteome Res 14:1183–1194
21.
go back to reference Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81:6656–6667PubMedCrossRef Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81:6656–6667PubMedCrossRef
23.
24.
go back to reference Messana I, Forni F, Ferrari F, Rossi C, Giardina B, Zuppi C (1998) Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients. Clin Chem 44:1529–1534PubMed Messana I, Forni F, Ferrari F, Rossi C, Giardina B, Zuppi C (1998) Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients. Clin Chem 44:1529–1534PubMed
25.
go back to reference Adams SH (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr Res (Bethesda, MD) 2:445–456 Adams SH (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr Res (Bethesda, MD) 2:445–456
26.
go back to reference Bingham C, Ellard S, Nicholls AJ et al (2001) The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria. Diabetes 50:2047–2052PubMedCrossRef Bingham C, Ellard S, Nicholls AJ et al (2001) The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria. Diabetes 50:2047–2052PubMedCrossRef
27.
go back to reference Landaas S (1975) Accumulation of 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid and 3-hydroxyisovaleric acid in ketoacidosis. Clin Chim Acta Int J Clin Chem 64:143–154CrossRef Landaas S (1975) Accumulation of 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid and 3-hydroxyisovaleric acid in ketoacidosis. Clin Chim Acta Int J Clin Chem 64:143–154CrossRef
28.
go back to reference Patterson AD, Bonzo JA, Li F et al (2011) Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J Biol Chem 286:19511–19522PubMedCentralPubMedCrossRef Patterson AD, Bonzo JA, Li F et al (2011) Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J Biol Chem 286:19511–19522PubMedCentralPubMedCrossRef
29.
go back to reference Cook DG, Shaper AG, Thelle DS, Whitehead TP (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006PubMedCentralPubMedCrossRef Cook DG, Shaper AG, Thelle DS, Whitehead TP (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006PubMedCentralPubMedCrossRef
30.
go back to reference Herman JB, Goldbourt U (1982) Uric acid and diabetes: observations in a population study. Lancet 2:240–243PubMedCrossRef Herman JB, Goldbourt U (1982) Uric acid and diabetes: observations in a population study. Lancet 2:240–243PubMedCrossRef
31.
go back to reference Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H (1988) Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol 127:321–336PubMed Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H (1988) Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol 127:321–336PubMed
32.
go back to reference Whitehead TP, Jungner I, Robinson D, Kolar W, Pearl A, Hale A (1992) Serum urate, serum glucose and diabetes. Ann Clin Biochem 29(Pt 2):159–161PubMedCrossRef Whitehead TP, Jungner I, Robinson D, Kolar W, Pearl A, Hale A (1992) Serum urate, serum glucose and diabetes. Ann Clin Biochem 29(Pt 2):159–161PubMedCrossRef
33.
go back to reference Ferrannini E, Natali A, Camastra S et al (2013) Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62:1730–1737PubMedCentralPubMedCrossRef Ferrannini E, Natali A, Camastra S et al (2013) Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62:1730–1737PubMedCentralPubMedCrossRef
35.
go back to reference Wurtz P, Soininen P, Kangas AJ et al (2013) Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36:648–655PubMedCentralPubMedCrossRef Wurtz P, Soininen P, Kangas AJ et al (2013) Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36:648–655PubMedCentralPubMedCrossRef
36.
go back to reference Williamson DH, Ellington EV (1975) Hydroxypyruvate as a gluconeogenic substrate in rat hepatocytes. Biochem J 146:277–279PubMedCentralPubMed Williamson DH, Ellington EV (1975) Hydroxypyruvate as a gluconeogenic substrate in rat hepatocytes. Biochem J 146:277–279PubMedCentralPubMed
37.
go back to reference Goldstein DS, Eisenhofer G, Kopin IJ (2003) Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305:800–811PubMedCrossRef Goldstein DS, Eisenhofer G, Kopin IJ (2003) Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305:800–811PubMedCrossRef
38.
go back to reference Aung MH, Park HN, Han MK et al (2014) Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci Off J Soc Neurosci 34:726–736CrossRef Aung MH, Park HN, Han MK et al (2014) Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci Off J Soc Neurosci 34:726–736CrossRef
39.
go back to reference Faresjo T, Faresjo A (2010) To match or not to match in epidemiological studies–same outcome but less power. Int J Environ Res Public Health 7:325–332PubMedCentralPubMedCrossRef Faresjo T, Faresjo A (2010) To match or not to match in epidemiological studies–same outcome but less power. Int J Environ Res Public Health 7:325–332PubMedCentralPubMedCrossRef
40.
go back to reference de Graaf MA, Jager KJ, Zoccali C, Dekker FW (2011) Matching, an appealing method to avoid confounding? Nephron Clin Pract 118:c315–c318PubMedCrossRef de Graaf MA, Jager KJ, Zoccali C, Dekker FW (2011) Matching, an appealing method to avoid confounding? Nephron Clin Pract 118:c315–c318PubMedCrossRef
41.
go back to reference Lu J, Zhou J, Bao Y et al (2012) Serum metabolic signatures of fulminant type 1 diabetes. J Proteome Res 11:4705–4711PubMedCrossRef Lu J, Zhou J, Bao Y et al (2012) Serum metabolic signatures of fulminant type 1 diabetes. J Proteome Res 11:4705–4711PubMedCrossRef
42.
go back to reference Wijekoon EP, Brosnan ME, Brosnan JT (2007) Homocysteine metabolism in diabetes. Biochem Soc Trans 35:1175–1179PubMedCrossRef Wijekoon EP, Brosnan ME, Brosnan JT (2007) Homocysteine metabolism in diabetes. Biochem Soc Trans 35:1175–1179PubMedCrossRef
43.
go back to reference Szabo A, Kenesei E, Korner A, Miltenyi M, Szucs L, Nagy I (1991) Changes in plasma and urinary amino acid levels during diabetic ketoacidosis in children. Diabetes Res Clin Pract 12:91–97PubMedCrossRef Szabo A, Kenesei E, Korner A, Miltenyi M, Szucs L, Nagy I (1991) Changes in plasma and urinary amino acid levels during diabetic ketoacidosis in children. Diabetes Res Clin Pract 12:91–97PubMedCrossRef
44.
go back to reference Tuma P, Samcova E, Balinova P (2005) Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Anal Technol Biomed Life Sci 821:53–59CrossRef Tuma P, Samcova E, Balinova P (2005) Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Anal Technol Biomed Life Sci 821:53–59CrossRef
45.
go back to reference Zhou Y, Qiu L, Xiao Q et al (2013) Obesity and diabetes related plasma amino acid alterations. Clin Biochem 46:1447–1452PubMedCrossRef Zhou Y, Qiu L, Xiao Q et al (2013) Obesity and diabetes related plasma amino acid alterations. Clin Biochem 46:1447–1452PubMedCrossRef
46.
go back to reference Eremina IA, Mamaeva GG, Likhacheva NV, Burobin VA (1986) Urocanic acid content of the epidermis of diabetics. Probl Endokrinol (Mosk.) 32:15–18 Eremina IA, Mamaeva GG, Likhacheva NV, Burobin VA (1986) Urocanic acid content of the epidermis of diabetics. Probl Endokrinol (Mosk.) 32:15–18
47.
go back to reference Zhang AH, Sun H, Yan GL, Yuan Y, Han Y, Wang XJ (2014) Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods. J Physiol Biochem 70:117–128PubMedCrossRef Zhang AH, Sun H, Yan GL, Yuan Y, Han Y, Wang XJ (2014) Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods. J Physiol Biochem 70:117–128PubMedCrossRef
48.
go back to reference Olmos JM, Garcia MT, Amado JA, Gonzalez-Macias J (1996) Urine hydroxyproline increase in patients with diabetes mellitus. Diabet Med J Br Diabet Assoc 13:284CrossRef Olmos JM, Garcia MT, Amado JA, Gonzalez-Macias J (1996) Urine hydroxyproline increase in patients with diabetes mellitus. Diabet Med J Br Diabet Assoc 13:284CrossRef
49.
go back to reference Zhao Y, Fu L, Li R et al (2012) Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med 10:153PubMedCentralPubMedCrossRef Zhao Y, Fu L, Li R et al (2012) Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med 10:153PubMedCentralPubMedCrossRef
50.
go back to reference Avogaro A, Bier DM (1989) Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res 30:1811–1817PubMed Avogaro A, Bier DM (1989) Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res 30:1811–1817PubMed
51.
go back to reference Liebich HM, Forst C (1984) Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis. J Chromatogr 309:225–242PubMedCrossRef Liebich HM, Forst C (1984) Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis. J Chromatogr 309:225–242PubMedCrossRef
54.
go back to reference Yamanouchi T, Ogata N, Tagaya T et al (1996) Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 347:1514–1518PubMedCrossRef Yamanouchi T, Ogata N, Tagaya T et al (1996) Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 347:1514–1518PubMedCrossRef
55.
go back to reference Scheijen JL, Hanssen NM, van de Waarenburg MP, Jonkers DM, Stehouwer CD, Schalkwijk CG (2012) L(+) and D(-) lactate are increased in plasma and urine samples of type 2 diabetes as measured by a simultaneous quantification of L(+) and D(-) lactate by reversed-phase liquid chromatography tandem mass spectrometry. Exp Diabetes Res 2012:234812PubMedCentralPubMedCrossRef Scheijen JL, Hanssen NM, van de Waarenburg MP, Jonkers DM, Stehouwer CD, Schalkwijk CG (2012) L(+) and D(-) lactate are increased in plasma and urine samples of type 2 diabetes as measured by a simultaneous quantification of L(+) and D(-) lactate by reversed-phase liquid chromatography tandem mass spectrometry. Exp Diabetes Res 2012:234812PubMedCentralPubMedCrossRef
56.
go back to reference Busch M, Franke S, Muller A et al (2004) Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int 66:338–347PubMedCrossRef Busch M, Franke S, Muller A et al (2004) Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int 66:338–347PubMedCrossRef
57.
go back to reference Trevisan R, Nosadini R, Avogaro A et al (1986) Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism. J Clin Endocrinol Metab 62:1155–1162PubMedCrossRef Trevisan R, Nosadini R, Avogaro A et al (1986) Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism. J Clin Endocrinol Metab 62:1155–1162PubMedCrossRef
58.
go back to reference Sheikh-Ali M, Karon BS, Basu A et al (2008) Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care 31:643–647PubMedCrossRef Sheikh-Ali M, Karon BS, Basu A et al (2008) Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care 31:643–647PubMedCrossRef
59.
go back to reference Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ (1984) Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 30:426–432PubMed Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ (1984) Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 30:426–432PubMed
60.
go back to reference Brennan L, Corless M, Hewage C et al (2003) 13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and gamma-glutamyl cycle activity in a clonal pancreatic beta-cell line. Diabetologia 46:1512–1521PubMedCrossRef Brennan L, Corless M, Hewage C et al (2003) 13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and gamma-glutamyl cycle activity in a clonal pancreatic beta-cell line. Diabetologia 46:1512–1521PubMedCrossRef
Metadata
Title
A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
Authors
Noha A. Yousri
Dennis O. Mook-Kanamori
Mohammed M. El-Din Selim
Ahmed H. Takiddin
Hala Al-Homsi
Khoulood A. S. Al-Mahmoud
Edward D. Karoly
Jan Krumsiek
Kieu Thinh Do
Ulrich Neumaier
Marjonneke J. Mook-Kanamori
Jillian Rowe
Omar M. Chidiac
Cindy McKeon
Wadha A. Al Muftah
Sara Abdul Kader
Gabi Kastenmüller
Karsten Suhre
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3636-2

Other articles of this Issue 8/2015

Diabetologia 8/2015 Go to the issue